Shawn D. Spencer, Ph.D. - Publications

2004 Temple University, Philadelphia, PA, United States 
Pharmaceutical Chemistry, Biochemistry

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Andey T, Patel A, Marepally S, Chougule M, Spencer SD, Rishi AK, Singh M. Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine. Plos One. 11: e0146804. PMID 26757437 DOI: 10.1371/journal.pone.0146804  1
2013 Peer CJ, Brown JL, Martin TJ, Roth J, Spencer SD, Brassil P, McNeill KA, Kreisl TN, Fine HA, Figg WD. A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 942: 107-12. PMID 24239935 DOI: 10.1016/j.jchromb.2013.10.023  1
2013 Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD. Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. Bju International. 111: 1269-80. PMID 23419134 DOI: 10.1111/j.1464-410X.2012.11667.x  1
2013 Peer CJ, Rao M, Spencer SD, Shahbazi S, Steeg PS, Schrump DS, Figg WD. A rapid ultra HPLC-MS/MS method for the quantitation and pharmacokinetic analysis of 3-deazaneplanocin A in mice. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 927: 142-6. PMID 23352636 DOI: 10.1016/j.jchromb.2013.01.003  1
2013 Gao R, Reece KM, Sissung T, Fu SH, Venzon DJ, Reed E, Spencer SD, Price DK, Figg WD. Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N? Bmj Open. 3. PMID 23293248 DOI: 10.1136/bmjopen-2012-002030  1
2013 Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, et al. Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood. 121: 476-84. PMID 23212516 DOI: 10.1182/blood-2012-08-450585  1
2013 Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, et al. The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenetics and Genomics. 23: 1-8. PMID 23111421 DOI: 10.1097/FPC.0b013e32835aa8a2  1
2012 Troutman SM, Sissung TM, Cropp CD, Venzon DJ, Spencer SD, Adesunloye BA, Huang X, Karzai FH, Price DK, Figg WD. Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis. The Oncologist. 17: 312-20. PMID 22382457 DOI: 10.1634/theoncologist.2011-0315  1
2012 Patel AR, Spencer SD, Chougule MB, Safe S, Singh M. Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM). European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 46: 8-16. PMID 22342559 DOI: 10.1016/j.ejps.2012.01.012  1
2012 Chen X, Peer CJ, Alfaro R, Tian T, Spencer SD, Figg WD. Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization. Journal of Pharmaceutical and Biomedical Analysis. 62: 140-8. PMID 22305081 DOI: 10.1016/j.jpba.2012.01.008  1
2012 Peer CJ, Spencer SD, VanDenBerg DA, Pacanowski MA, Horenstein RB, Figg WD. A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 880: 132-9. PMID 22169056 DOI: 10.1016/j.jchromb.2011.11.029  1
2011 Li H, Qiang F, Yang Z, Spencer SD, Cui X, Wu X, Chen X. Hepatitis B virus with pre-S2 deletion is more prevalent in hepatocellular carcinoma than in chronic active hepatitis and asymptomatic carriers. Acta Virologica. 55: 183-5. PMID 21692570 DOI: 10.4149/av_2011_02_183  1
2011 Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, et al. Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5123-31. PMID 21673063 DOI: 10.1158/1078-0432.CCR-11-0682  1
2010 Billups J, Jones C, Jackson TL, Ablordeppey SY, Spencer SD. Simultaneous RP-HPLC-DAD quantification of bromocriptine, haloperidol and its diazepane structural analog in rat plasma with droperidol as internal standard for application to drug-interaction pharmacokinetics. Biomedical Chromatography : Bmc. 24: 699-705. PMID 19908205 DOI: 10.1002/bmc.1349  1
2004 Spencer SD, Raffa RB. Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition. Pharmaceutical Research. 21: 1642-7. PMID 15497691 DOI: 10.1023/B:PHAM.0000041460.78128.0f  1
2004 Raffa RB, Stagliano GW, Spencer SD. Protonation effect on drug affinity. European Journal of Pharmacology. 483: 323-4. PMID 14729124 DOI: 10.1016/j.ejphar.2003.10.019  1
2002 Raffa RB, Spencer SD, Schulingkamp RJ. Toward RNase inhibitors: thermodynamics of 2'-CMP/RNase-A binding in multi-ion buffer. Biochemical Pharmacology. 63: 1937-9. PMID 12093469 DOI: 10.1016/S0006-2952(02)00977-2  1
2002 Spencer SD, Abdul O, Schulingkamp RJ, Raffa RB. Toward the design of ribonuclease (RNase) inhibitors: ion effects on the thermodynamics of binding of 2'-CMP to RNase A. The Journal of Pharmacology and Experimental Therapeutics. 301: 925-9. PMID 12023520 DOI: 10.1124/jpet.301.3.925  1
Show low-probability matches.